Key result
Qi Dan Li Xin Pill significantly improved left ventricular remodeling and cardiac function (P < 0.01) in rats with chronic heart failure by regulating mTOR/p70S6k-mediated autophagy and inhibiting apoptosis.
Why the study?
Myocardial remodeling is a key factor in chronic heart failure development, and this study evaluated the effects of Qi Dan Li Xin Pill on cardiac function, inflammatory factors, autophagy, and apoptosis in post-myocardial infarction rats.
Does Qi Dan Li Xin Pill improve cardiac remodeling and function in a rat model of chronic heart failure?
Does Qi Dan Li Xin Pill improve cardiac remodeling and function in a rat model of chronic heart failure?
p-value: p=<0.01
Qi Dan Li Xin Pill demonstrates cardioprotective effects in a rat model of post-MI heart failure by modulating inflammation, apoptosis, and autophagy via the mTOR/P70S6K pathway.
Myocardial remodeling represents a key factor in chronic heart failure (CHF) development, and is characterized by chronic death of cardiomyocytes. Cardiac function changes may be attributed to inflammation, apoptosis and autophagy. This study assessed the effects of Qi Dan Li Xin Pill (QD) on heart function, inflammatory factors, autophagy and apoptosis in cardiac remodeling in CHF rats upon myocardial infarction (MI) induction. Male SD rats underwent a sham procedure or left anterior descending coronary artery (LADCA) ligation, causing MI. Twenty-eight days after modeling, the animals were treated daily with QD, valsartan and saline for 4 weeks. Echocardiography after 4 weeks of drug intervention revealed substantially improved left ventricular remodeling and cardiac function following QD treatment. As demonstrated by decreased IL-1β, IL-6 and TNF-α amounts, this treatment also inhibited the apoptotic process and protected the viability of the myocardium. These outcomes may be attributed to enhanced autophagy in cardiomyocytes, which further reduced pro-inflammatory and pro apoptotic effects. This process may be achieved by QD regulation of the mTOR/P70S6K signaling pathway, suggesting that the traditional Chinese medicine Qi Dan Li Xin pill is effective in heart protective treatment, and is worth further investigation.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2020) studied Chronic heart failure post-myocardial infarction (n=90). Qi Dan Li Xin Pill vs. Normal saline (untreated model) and Valsartan (10 mg/kg/d) was evaluated on Left ventricular ejection fraction (EF) and fractional shortening (FS) (p=<0.01). Qi Dan Li Xin Pill significantly improved left ventricular remodeling and cardiac function (P < 0.01) in rats with chronic heart failure by regulating mTOR/p70S6k-mediated autophagy and inhibiting apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: